RxDoctor Payments Data

Jennifer Wright, MD

Clinical Cardiac Electrophysiology · Madison, WINPI 1669661013

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,988 of the $34,866 with a category attached, or 77.4%. 10 manufacturers reported payments, led by Biosense Webster, Inc. at 32.4% of the total.

$34,866in general payments, 2019–2025

Across 53 payments — averaging $657.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$11K
  • Medical Device Business Services, Inc.$10K
  • Edwards Lifesciences$7K
  • Boston Scientific$5K
  • Abbott$1K
  • Atricure, Inc.$131
  • plus $78 from 4 others

What the payments were for

  • Consulting fees$26,98877%
  • Speaking & faculty fees$1,2504%
  • Travel & lodging$4,31612%
  • Food & beverage$2,3127%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,866 in reported general payments places this provider in the 75th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

See all clinical cardiac electrophysiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$144,421
Medicare patients
743
Services billed
1,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban336$441,040
XareltoRivaroxaban41$64,571
FarxigaDapagliflozin Propanediol11$14,403
Flecainide Acetate149$5,347
Metoprolol Succinate270$5,332
Amiodarone Hcl143$3,326
Candesartan Cilexetil21$2,111
Diltiazem 24hr Er (Cd)Diltiazem Hcl54$1,213
Irbesartan28$1,163
Nadolol25$1,064
SotalolSotalol Hcl23$853
Atenolol19$433
Carvedilol40$411
Diltiazem 24hr ErDiltiazem Hcl11$301
Pantoprazole Sodium47$300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$34$14,40311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

Other clinical cardiac electrophysiology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →